RxDoctor Payments DataLook up a doctor →

Setsuko Chambers, MD

Gynecologic Oncology · Tucson, AZNPI 1801869300

Payments from drug & device makers

$1,348,469in general payments, 2019–2025

Across 258 payments — averaging $5226.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$656K
  • Clovis Oncology, Inc.$244K
  • F. Hoffmann-la Roche AG$131K
  • AstraZeneca$120K
  • Genmab U.S., Inc.$53K
  • Immunogen, Inc.$38K
  • plus $108K from 7 others
$1,200in research payments, 2019–2025

Across 8 payments — averaging $150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Tesaro, Inc.$1K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,348,469 in reported general payments places this provider in the 90th percentile of 26 gynecologic oncology providers in Arizona.

See all gynecologic oncology providers in Arizona

Medicare billing

Part B allowed, 2024
$42,205
Medicare patients
72
Services billed
396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →